Haba Laboratories Inc. said its normalized net income for the fiscal third quarter ended Dec. 31, 2015, came to ¥126.15 per share, a gain from ¥15.73 per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥496.3 million, an increase from ¥61.9 million in the prior-year period.

The normalized profit margin rose to 12.3% from 1.7% in the year-earlier period.

Total revenue climbed 9.3% on an annual basis to ¥4.03 billion from ¥3.69 billion, and total operating expenses fell 8.4% on an annual basis to ¥3.27 billion from ¥3.58 billion.

Reported net income increased from the prior-year period to ¥508.0 million, or ¥129.14 per share, from ¥136.0 million, or ¥34.57 per share.

As of Feb. 15, US$1 was equivalent to ¥114.50.